Rhythm Pharmaceuticals (RYTM) PT Raised to $50 at Stifel
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $118.08 +0.41%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Stifel analyst Dae Gon Ha raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $50.00 (from $44.00) while maintaining a Buy rating.
You May Also Be Interested In
- UK regulator expands Imcivree approval to hypothalamic obesity
- Hyundai Heavy Industries (329180:KS) PT Raised to KRW2,710 at Nomura/Instinet
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
